
Reset all filters
01 2APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
02 1ARAGEN LIFE SCIENCES LIMITED Hyderabad IN
03 2BAYER AG Leverkusen DE
04 1CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. Chongqing CN
05 1CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram IN
06 2DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
07 1HEC API YICHANG CO., LTD. Yidu City CN
08 1HEC PHARM GMBH Berlin DE
09 1HETERO DRUGS LIMITED Hyderabad IN
10 1HISUN PHARMACEUTICAL (NANTONG) CO., LTD. Nantong City CN
11 1INNOVARE LABS PRIVATE LIMITED Visakhapatnam IN
12 1MACLEODS PHARMACEUTICALS LIMITED Mumbai IN
13 1MICRO LABS LIMITED Bengaluru IN
14 2MSN PHARMACHEM PRIVATE LIMITED Sangareddy District IN
15 1NOSCH LABS PRIVATE LIMITED Hyderabad IN
16 1OLON S.P.A. Rodano IT
17 1RUYUAN HEC PHARM CO., LTD. Shaoguan CN
18 1SHAANXI DASHENG PHARMACEUTICAL TECH CO., LTD. Xi’an CN
19 1TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
20 1ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shangyu CN
21 1ZHEJIANG NHU COMPANY LTD. Shaoxing City CN
Reset all filters
01 16Moxifloxacin hydrochloride
02 1Moxifloxacin hydrochloride, Anhydrous
03 1Moxifloxacin hydrochloride, For use in the manufacture of parenteral preparations
04 2Moxifloxacin hydrochloride, Monohydrate
05 1Moxifloxacin hydrochloride, Monohydrate, micronised and non-micronised
06 1Moxifloxacin hydrochloride, Process II
07 1Moxifloxacin hydrochloride, Process-II
08 1Moxifloxacin hydrochloride, Site 2
09 1Moxifloxacin hydrochloride, Site 3
Reset all filters
01 8China
02 1Gabon
03 2Germany
04 13India
05 1Italy
Reset all filters
01 21Valid
02 4Withdrawn by Holder
Moxifloxacin Hydrochloride, Process-II
Certificate Number : CEP 2024-302 - Rev 00
Status : Valid
Issue Date : 2024-11-18
Type : Chemical
Substance Number : 2254
Certificate Number : CEP 2008-067 - Rev 03
Status : Valid
Issue Date : 2024-06-05
Type : Chemical
Substance Number : 2254
Certificate Number : CEP 2016-327 - Rev 04
Status : Valid
Issue Date : 2023-10-31
Type : Chemical
Substance Number : 2254
Certificate Number : CEP 2013-225 - Rev 03
Status : Valid
Issue Date : 2024-12-03
Type : Chemical
Substance Number : 2254
Certificate Number : CEP 2017-113 - Rev 02
Status : Valid
Issue Date : 2025-03-06
Type : Chemical
Substance Number : 2254
Moxifloxacin Hydrochloride, Anhydrous
Certificate Number : CEP 2015-360 - Rev 02
Status : Valid
Issue Date : 2024-04-30
Type : Chemical
Substance Number : 2254
Certificate Number : R1-CEP 2015-316 - Rev 00
Status : Valid
Issue Date : 2022-07-11
Type : Chemical
Substance Number : 2254
Certificate Number : R0-CEP 2018-298 - Rev 00
Status : Valid
Issue Date : 2020-09-23
Type : Chemical
Substance Number : 2254
Certificate Number : CEP 2013-201 - Rev 03
Status : Valid
Issue Date : 2024-07-19
Type : Chemical
Substance Number : 2254
Moxifloxacin Hydrochloride, Process II
Certificate Number : CEP 2013-078 - Rev 01
Status : Valid
Issue Date : 2024-08-21
Type : Chemical
Substance Number : 2254
30
PharmaCompass offers a list of Moxifloxacin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Moxifloxacin Hydrochloride manufacturer or Moxifloxacin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Moxifloxacin Hydrochloride manufacturer or Moxifloxacin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Moxifloxacin Hydrochloride API Price utilized in the formulation of products. Moxifloxacin Hydrochloride API Price is not always fixed or binding as the Moxifloxacin Hydrochloride Price is obtained through a variety of data sources. The Moxifloxacin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Moxeza manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Moxeza, including repackagers and relabelers. The FDA regulates Moxeza manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Moxeza API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Moxeza manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Moxeza supplier is an individual or a company that provides Moxeza active pharmaceutical ingredient (API) or Moxeza finished formulations upon request. The Moxeza suppliers may include Moxeza API manufacturers, exporters, distributors and traders.
click here to find a list of Moxeza suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Moxeza CEP of the European Pharmacopoeia monograph is often referred to as a Moxeza Certificate of Suitability (COS). The purpose of a Moxeza CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Moxeza EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Moxeza to their clients by showing that a Moxeza CEP has been issued for it. The manufacturer submits a Moxeza CEP (COS) as part of the market authorization procedure, and it takes on the role of a Moxeza CEP holder for the record. Additionally, the data presented in the Moxeza CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Moxeza DMF.
A Moxeza CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Moxeza CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Moxeza suppliers with CEP (COS) on PharmaCompass.
We have 18 companies offering Moxeza
Get in contact with the supplier of your choice: